 |
|
The Association between Treatment with Bisphosphonates and the Risk of Atrial Fibrillation: A Meta-Analysis of Observational Studies
Ji-Hyun Park, Hae-Jin Ko
Korean J Fam Med. 2022;43(1):69-76. Published online 2022 Jan 20 DOI: https://doi.org/10.4082/kjfm.21.0110
|
|
Citations to this article as recorded by
 Polyphyllin VI: A promising treatment for prostate cancer bone metastasis
Yanbin Feng, Yaomin Mo, Yang Zhang, Yilin Teng, Deshuang Xi, Junhong Zhou, Gaofeng Zeng, Shaohui Zong
International Immunopharmacology.2025; 144: 113684. CrossRef Prevalence and Clinical Implications of Osteosarcopenia in Patients With Acute Stroke
Kyoung Tae Kim, Soyoung Lee, Jang Hyuk Cho, Yongmin Choi
American Journal of Physical Medicine & Rehabilitation.2025; 104(2): 101. CrossRef Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond
Alexandru Florin Florescu, Oana-Claudia Sima, Mihai Costăchescu, Mihaela Stanciu, Ligia Florina Popa, Claudiu Nistor, Mădălina Gabriela Iliescu, Mihai-Lucian Ciobica, Mara Carsote
Balneo and PRM Research Journal.2024; 15(Vol.15, no): 704. CrossRef Additional effects of herbal medicine combined with bisphosphonates for primary osteoporosis: a systematic review and meta-analysis
Young-Seo Yoo, Min-Gyeong Kim, Hee-Joo Park, Min-Young Chae, Yu-Jin Choi, Chae-Kun Oh, Chang-Gue Son, Eun-Jung Lee
Frontiers in Pharmacology.2024;[Epub] CrossRef Association of oral bisphosphonates with cardioembolic ischemic stroke: a nested case-control study
Sara Rodríguez-Martín, Diana Barreira-Hernández, Ramón Mazzucchelli, Miguel Gil, Alberto García-Lledó, Laura Izquierdo-Esteban, Ana Pérez-Gómez, Antonio Rodríguez-Miguel, Francisco J. De Abajo
Frontiers in Pharmacology.2023;[Epub] CrossRef
|